KALV – KalVista Pharmaceuticals Inc
KALV — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
51.54
Margin Of Safety %
Put/Call OI Ratio
0.52
EPS Next Q Diff
EPS Last/This Y
2.74
EPS This/Next Y
2.01
Price
20.13
Target Price
34.33
Analyst Recom
1
Performance Q
28.48
Upside
-795.8%
Beta
-0.39
Ticker: KALV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | KALV | 17.29 | 1.51 | 0.00 | 18719 |
| 2026-03-10 | KALV | 18.42 | 1.51 | 0.02 | 18723 |
| 2026-03-11 | KALV | 18.23 | 1.41 | 0.01 | 19273 |
| 2026-03-12 | KALV | 17.4 | 1.37 | 2.48 | 19517 |
| 2026-03-13 | KALV | 17.38 | 1.37 | 2.19 | 19517 |
| 2026-03-17 | KALV | 16.56 | 1.34 | 0.20 | 19649 |
| 2026-03-18 | KALV | 15.49 | 1.34 | 0.05 | 19672 |
| 2026-03-20 | KALV | 17 | 1.33 | 4.48 | 19762 |
| 2026-03-25 | KALV | 17.11 | 1.45 | 0.15 | 17578 |
| 2026-03-26 | KALV | 18.83 | 1.45 | 0.00 | 17597 |
| 2026-03-27 | KALV | 19.3 | 0.71 | 0.02 | 24987 |
| 2026-03-30 | KALV | 18.37 | 0.53 | 0.55 | 30512 |
| 2026-03-31 | KALV | 20.15 | 0.53 | 0.13 | 30686 |
| 2026-04-01 | KALV | 19.76 | 0.53 | 0.00 | 30750 |
| 2026-04-06 | KALV | 20.28 | 0.53 | 0.00 | 30789 |
| 2026-04-07 | KALV | 20.13 | 0.52 | 0.28 | 30916 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | KALV | 17.29 | - | - | - |
| 2026-03-10 | KALV | 18.43 | - | - | - |
| 2026-03-11 | KALV | 18.22 | - | - | - |
| 2026-03-12 | KALV | 17.39 | - | - | - |
| 2026-03-13 | KALV | 16.95 | - | - | - |
| 2026-03-17 | KALV | 16.58 | - | - | - |
| 2026-03-18 | KALV | 15.51 | - | - | - |
| 2026-03-19 | KALV | 16.44 | - | - | - |
| 2026-03-20 | KALV | 17.03 | - | - | - |
| 2026-03-23 | KALV | 16.59 | - | - | - |
| 2026-03-24 | KALV | 16.49 | - | - | - |
| 2026-03-25 | KALV | 17.11 | - | - | - |
| 2026-03-26 | KALV | 18.97 | - | - | - |
| 2026-03-27 | KALV | 19.30 | - | - | - |
| 2026-03-30 | KALV | 18.35 | - | - | -1.34 |
| 2026-03-31 | KALV | 20.14 | - | - | -1.34 |
| 2026-04-01 | KALV | 19.76 | - | - | -1.34 |
| 2026-04-02 | KALV | 19.90 | - | - | -1.34 |
| 2026-04-06 | KALV | 20.20 | - | - | -0.95 |
| 2026-04-07 | KALV | 20.13 | - | - | -0.95 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | KALV | -0.66 | 11.73 | 53.21 |
| 2026-03-10 | KALV | -0.61 | 11.73 | 53.21 |
| 2026-03-11 | KALV | -0.66 | 11.73 | 51.82 |
| 2026-03-12 | KALV | -0.66 | 11.73 | 51.82 |
| 2026-03-13 | KALV | -0.66 | 11.73 | 51.82 |
| 2026-03-18 | KALV | -0.66 | 11.75 | 51.82 |
| 2026-03-19 | KALV | -0.66 | 11.75 | 51.82 |
| 2026-03-20 | KALV | -0.66 | 11.75 | 51.82 |
| 2026-03-23 | KALV | -0.66 | 11.76 | 51.82 |
| 2026-03-24 | KALV | -0.66 | 11.76 | 51.82 |
| 2026-03-25 | KALV | -0.66 | 11.76 | 52.23 |
| 2026-03-26 | KALV | -0.66 | 11.76 | 52.23 |
| 2026-03-27 | KALV | -2.19 | 11.76 | 52.23 |
| 2026-03-30 | KALV | -2.19 | 11.77 | 51.54 |
| 2026-03-31 | KALV | -2.19 | 11.77 | 51.54 |
| 2026-04-01 | KALV | -2.19 | 11.77 | 51.54 |
| 2026-04-02 | KALV | -2.19 | 11.77 | 51.54 |
| 2026-04-06 | KALV | -2.19 | 11.60 | 51.54 |
| 2026-04-07 | KALV | -2.19 | 11.60 | 51.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.4
Avg. EPS Est. Next Quarter
-0.27
Insider Transactions
-2.19
Institutional Transactions
11.6
Beta
-0.39
Average Sales Estimate Current Quarter
39
Average Sales Estimate Next Quarter
47
Fair Value
Quality Score
29
Growth Score
29
Sentiment Score
76
Actual DrawDown %
34.4
Max Drawdown 5-Year %
-86
Target Price
34.33
P/E
Forward P/E
42.29
PEG
P/S
720.7
P/B
P/Free Cash Flow
EPS
-4
Average EPS Est. Cur. Y
-0.95
EPS Next Y. (Est.)
1.05
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-14242.57
Relative Volume
1.17
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
0.5
EPS 1 30Days Diff
0.5
EBIT Estimation
◆
KALV
Healthcare
$20.12
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
65.5
Range 1M
81.9%
Sup Dist
2.4%
Momentum Growth
Ride accelerating trends
WATCH
EPS Yr
53.3%
EPS NY
150.2%
52W%
90.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+79.2% upside
Upside
+79.2%
Quality
29
KalVista Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
KALV
Latest News
—
Caricamento notizie per KALV…
stock quote shares KALV – KalVista Pharmaceuticals Inc Stock Price stock today
news today KALV – KalVista Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KALV – KalVista Pharmaceuticals Inc yahoo finance google finance
stock history KALV – KalVista Pharmaceuticals Inc invest stock market
stock prices KALV premarket after hours
ticker KALV fair value insiders trading